Oncotelic Therapeutics, Inc. Quarterly Current Ratio in % from Q1 2012 to Q3 2024

Taxonomy & unit
ratio: %
Description
The current ratio is a liquidity ratio that measures a company's ability to cover its short-term obligations with its current assets.
Summary
Oncotelic Therapeutics, Inc. quarterly Current Ratio history and growth rate from Q1 2012 to Q3 2024.
  • Oncotelic Therapeutics, Inc. Current Ratio for the quarter ending September 30, 2024 was 1.42 %, a 15.9% decline year-over-year.
Current Ratio, Quarterly (%)
Current Ratio, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date
Q3 2024 1.42 -0.27 -15.9% Sep 30, 2024
Q2 2024 1.6 -0.04 -2.44% Jun 30, 2024
Q1 2024 1.69 -0.28 -14.3% Mar 31, 2024
Q4 2023 1.66 -0.21 -11.2% Dec 31, 2023
Q3 2023 1.7 -0.72 -29.8% Sep 30, 2023
Q2 2023 1.64 -0.63 -27.7% Jun 30, 2023
Q1 2023 1.96 -0.77 -28.2% Mar 31, 2023
Q4 2022 1.87 -2.42 -56.3% Dec 31, 2022
Q3 2022 2.42 -2.2 -47.6% Sep 30, 2022
Q2 2022 2.28 -5.7 -71.5% Jun 30, 2022
Q1 2022 2.73 -6.6 -70.7% Mar 31, 2022
Q4 2021 4.3 -4.34 -50.3% Dec 31, 2021
Q3 2021 4.62 -4.13 -47.2% Sep 30, 2021
Q2 2021 7.97 +2.63 +49.2% Jun 30, 2021
Q1 2021 9.33 +5.3 +132% Mar 31, 2021
Q4 2020 8.63 +1.77 +25.8% Dec 31, 2020
Q3 2020 8.75 -0.93 -9.61% Sep 30, 2020
Q2 2020 5.35 -31.3 -85.4% Jun 30, 2020
Q1 2020 4.03 -82.6 -95.3% Mar 31, 2020
Q4 2019 6.86 -74.4 Dec 31, 2019
Q3 2019 9.68 -72 -88.1% Sep 30, 2019
Q2 2019 36.6 -73.5 -66.8% Jun 30, 2019
Q1 2019 86.6 -102 -54.2% Mar 31, 2019
Q4 2018 81.2* -283 Dec 31, 2018
Q3 2018 81.7 -514 -86.3% Sep 30, 2018
Q2 2018 110 -700 -86.4% Jun 30, 2018
Q1 2018 189 -823 -81.3% Mar 31, 2018
Q4 2017 365 -761 -67.6% Dec 31, 2017
Q3 2017 596 -637 -51.7% Sep 30, 2017
Q2 2017 810 -569 -41.3% Jun 30, 2017
Q1 2017 1.01K -645 -38.9% Mar 31, 2017
Q4 2016 1.13K -1.01K -47.3% Dec 31, 2016
Q3 2016 1.23K -1.23K -50% Sep 30, 2016
Q2 2016 1.38K -1.15K -45.4% Jun 30, 2016
Q1 2016 1.66K -596 -26.5% Mar 31, 2016
Q4 2015 2.14K +188 +9.66% Dec 31, 2015
Q3 2015 2.47K +837 +51.3% Sep 30, 2015
Q2 2015 2.53K +1.25K +97.5% Jun 30, 2015
Q1 2015 2.25K +1.27K +130% Mar 31, 2015
Q4 2014 1.95K +1.29K +197% Dec 31, 2014
Q3 2014 1.63K +966 +145% Sep 30, 2014
Q2 2014 1.28K +633 +98.1% Jun 30, 2014
Q1 2014 981 +452 +85.4% Mar 31, 2014
Q4 2013 655 +122 +22.8% Dec 31, 2013
Q3 2013 664 +159 +31.4% Sep 30, 2013
Q2 2013 646 +169 +35.4% Jun 30, 2013
Q1 2013 529 +65.8 +14.2% Mar 31, 2013
Q4 2012 534 Dec 31, 2012
Q3 2012 506 Sep 30, 2012
Q2 2012 477 Jun 30, 2012
Q1 2012 463 Mar 31, 2012
* An asterisk sign (*) next to the value indicates that the value is likely invalid.